ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 623173 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 623173; 2) Community: the network communities that were significantly associated with the response to NSC 623173; 3) Molecule: the relationships between components within communities and NSC 623173; 4) MDR: the compounds that were significantly associated with the NSC 623173.

NSC Compound Enrichment Correlation
NSC 625817 Null 0.0112113991710615 0.48413127
NSC 626878 Cyclopentanone, 2-[(dimethylamino)methyl]-5-pentylidene-, hydrochloride 0.0112113991710615 0.38668611
NSC 634037 4-amino-3-bromo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazine 0.0112113991710615 0.47184826
NSC 635831 Null 0.0112113991710615 0.43882215
NSC 639976 Cyclopentanone, 2-[2-methyl-2-[4-(2-methylpropyl)- phenyl]ethylidene]-5-[(4-morpholinyl)methyl]-, hydrochloride 0.0112113991710615 0.35924951
NSC 644916 ANTINEOPLASTIC-644916 0.0112113991710615 0.43238349
NSC 645431 1H-Benz[g]indol-5-ol, 2-phenyl 0.0112113991710615 0.33658474
NSC 653823 Null 0.0112113991710615 0.3505112
NSC 655438 Null 0.0112113991710615 0.544618
NSC 659853 2-Methoxy-.beta.-estradiol 0.0112113991710615 0.34774664
Total:125  Current:36    [First] [Prev] [Next] [Last]